Corvus Pharmaceuticals (CRVS) Enterprise Value (2016 - 2026)
Corvus Pharmaceuticals (CRVS) recorded Enterprise Value of $1.04 billion in Q2 2026, up 267.6% from $283.37 million a year earlier and up 4.8% from the prior quarter.
Corvus Pharmaceuticals (CRVS) Enterprise Value (2016 - 2026) Analysis & Trends
On a TTM basis, Corvus Pharmaceuticals' Enterprise Value came in at $745.21 million as of Jun 30, 2026, up 236.1% year-over-year; for FY2025, it was $518.41 million, up 66.5% from FY2024.
- Annual Enterprise Value has increased for three straight years, with a five-year compound annual growth rate of 43.7% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $311.3 million in FY2024 (+322.5%), $73.69 million in FY2023 (+179.0%), $26.41 million in FY2022 (-45.8%) and $48.74 million in FY2021 (-42.4%).
- The Q2 2026 figure is the highest quarterly Enterprise Value in data going back to Q1 2016.
- On a year-over-year basis, Enterprise Value has increased for eight consecutive quarters, with growth averaging 247.2% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 532.6% in Q3 2024, against a decline of 91.1% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $993.53 million (Q1 2026), $518.41 million (Q4 2025) and $547.54 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Corvus Pharmaceuticals | 998.52 Mn | 486.96 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 Bn |
| Mar 31, 2026 | 993.53 Mn |
| Dec 31, 2025 | 518.41 Mn |
| Sep 30, 2025 | 547.54 Mn |
| Jun 30, 2025 | 283.37 Mn |
| Mar 31, 2025 | 211.78 Mn |
| Dec 31, 2024 | 311.30 Mn |
| Sep 30, 2024 | 325.74 Mn |
| Jun 30, 2024 | 99.00 Mn |
| Mar 31, 2024 | 79.83 Mn |
| Dec 31, 2023 | 73.69 Mn |
| Sep 30, 2023 | 51.49 Mn |
| Jun 30, 2023 | 104.32 Mn |
| Mar 31, 2023 | 32.72 Mn |
| Dec 31, 2022 | 26.41 Mn |
| Sep 30, 2022 | 13.59 Mn |
| Jun 30, 2022 | 17.61 Mn |
| Mar 31, 2022 | 44.89 Mn |
| Dec 31, 2021 | 48.74 Mn |
| Sep 30, 2021 | 152.99 Mn |
Corvus Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=CRVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();